BCM
AGN

Blume Capital Management’s Allergan plc AGN Stock Holding History

Blume Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-75
Closed -$13K – 249
2020
Q1 		$13K Hold
75
– – 0.01% 166
2019
Q4 		$14K Hold
75
– – 0.01% 173
2019
Q3 		$12K Sell
75
-22,838
-100% -$3.72M 0.01% 180
2019
Q2 		$3.84M Sell
22,913
-11,328
-33% -$1.57M 1.94% 22
2019
Q1 		$5.01M Sell
34,241
-85
-0.2% -$12.3K 2.63% 13
2018
Q4 		$4.59M Sell
34,326
-5,585
-14% -$916K 2.62% 14
2018
Q3 		$7.6M Sell
39,911
-750
-2% -$138K 3.97% 7
2018
Q2 		$6.78M Sell
40,661
-9,986
-20% -$1.6M 3.7% 11
2018
Q1 		$8.52M Sell
50,647
-145
-0.3% -$24.3K 4.74% 2
2017
Q4 		$8.31M Buy
50,792
+3,515
+7% +$631K 4.25% 3
2017
Q3 		$9.69M Buy
47,277
+5,884
+14% +$1.37M 5.12% 2
2017
Q2 		$10.1M Buy
41,393
+255
+0.6% +$59.9K 5.71% 2
2017
Q1 		$9.83M Buy
41,138
+145
+0.4% +$33.8K 5.69% 2
2016
Q4 		$8.61M Buy
40,993
+4,963
+14% +$1.03M 5.17% 2
2016
Q3 		$8.3M Buy
36,030
+1,025
+3% +$250K 5.08% 3
2016
Q2 		$8.09M Buy
35,005
+14,000
+67% +$3.23M 5.34% 3
2016
Q1 		$5.63M Buy
21,005
+5,715
+37% +$1.64M 3.89% 7
2015
Q4 		$4.78M Buy
15,290
+15,170
+12,642% +$4.52M 3.38% 12
2015
Q3 		$33K Buy
120
+100
+500% +$30.7K 0.03% 123
2015
Q2 		$6K Buy
+20
New +$5.96K ﹤0.01% 205

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Blume Capital Management's AGN Position: Q2 2020 in Review

Blume Capital Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 75 shares — an estimated $13K sold.

Blume Capital Management first reported a position in AGN in Q2 2015 and held it in 20 quarters. The position peaked at $10.1M in Q2 2017. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Blume Capital Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Blume Capital Management sold 75 Allergan plc shares in Q2 2020, an estimated $13K.
  • Blume Capital Management first reported a position in Allergan plc in Q2 2015 and held it in 20 quarters.
  • Blume Capital Management's Allergan plc position peaked at $10.1M in Q2 2017.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Blume Capital Management's 13F filing for Q2 2020, filed 6 Aug 2020.